Yahoo Finance

Interna Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance MNM-Based Targeted Delivery Technologies

PETACH TIKVA, Israel, April 16, 2026 /PRNewswire/ -- Interna Therapeutics, a clinical stage biotechnology company advancing its Molecular Nano Motor (MNM) intracellular delivery platform, today ...
Yahoo Finance

Daiichi Sankyo and Interna partner for MNM-targeted delivery solutions

The agreement allows for potential expansion into wider research and further programmes. Credit: M Isolation photo / Shutterstock.com. · Hospital Management · M Isolation photo / Shutterstock.com.
Business Wire

InteRNA Technologies Announces Dosing of First Patient in First-in-Human Trial of microRNA Drug Candidate INT-1B3 in Patients with Advanced Solid Tumors

UTRECHT, The Netherlands--(BUSINESS WIRE)--InteRNA Technologies announced today that the first patient has been dosed in the first cohort of its first-in-human Phase I study with the Company’s lead ...
Business Wire

InteRNA Technologies Establishes Clinical Advisory Board and Appoints New Members to Scientific Advisory Board

UTRECHT, The Netherlands--(BUSINESS WIRE)--InteRNA Technologies, a clinical-stage biotech company developing microRNA (miRNA)-based therapeutics with a focus on cancer, today announced the ...